Answers are grounded in this paper and cite their sources.
OBJECTIVE: To estimate the willingness to pay (WTP) per quality-adjusted life year (QALY) value for life-saving treatments and to determine factors affecting the WTP per QALY value. DESIGN: A cross-sectional survey with multistage sampling and face-to-face interviews. SETTING: General population in the southern part of Thailand. PARTICIPANTS: A total of 600 individuals were included in the study. Only 554 (92.3%) responses were usable for data analyses. OUTCOME MEASURE: Participants were asked for the maximum amount of WTP value for life-saving treatments by an open-ended question. EQ-5D-3L and visual analogue scale (VAS) were used to estimate additional QALY. RESULTS: The amount of WTP values varied from 0 to 720,000 Baht/year (approximately 32 Baht=US$1). The averages of additional QALY obtained from VAS and EQ-5D-3L were only slightly different (0.872 and 0.853, respectively). The averages of WTP per QALY obtained from VAS and EQ-5D-3L were 244,720 and 243,120 Baht/QALY, respectively. As compared to male participants, female participants were more likely to pay less for an additional QALY (p=0.007). In addition, participants with higher household incomes tended to have higher WTP per QALY values (p<0.001). CONCLUSIONS: Our study added another WTP per QALY value specifically for life-saving treatments, which would complement the current cost-effectiveness threshold used in Thailand and optimise patient access to innovative treatments or technologies.
No takes yet. Share an insight, caveat, or question.
Nimdet et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: